Search Results 61-70 of 18978 for Hepatitis C
This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.
Viral hepatitis (hepatitis B and hepatitis C). Metabolic dysfunction-associated steatotic liver disease — formerly known as nonalcoholic fatty liver disease ...
People with chronic liver disease, including hepatitis B or hepatitis C; Anyone wishing to obtain protection (immunity). If you're concerned about your risk ...
Left untreated, hepatitis C can cause serious liver damage, cirrhosis and even death. On the next Mayo Clinic Radio, infectious diseases specialist Dr. Stacey ...
For hepatitis C virus infection: Adults—One tablet once a day, taken for 12 weeks. Each tablet contains sofosbuvir 400 milligrams (mg) and velpatasvir 100 ...
Screening laboratory result indicating Hepatitis C Virus (HCV) Genotype (GT) 1, 2, 4, 5 or 6 infection. Positive plasma HCV antibody and HCV RNA viral load ...
During her three-day checkup, she was told that X-rays had found a cancerous tumor on her liver. So, instead of talking about her Hepatitis C treatments, she ...
Glecaprevir and pibrentasvir combination is used to treat chronic hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, or 6 infection in patients without cirrhosis ...
Peginterferon alfa-2a injection is used alone or together with other medicines (eg, ribavirin)to treat chronic hepatitis C infection in patients who are not ...
Medicines to control hepatitis. Medicines may limit further damage to liver cells caused by hepatitis B or C through specific treatment of these viruses.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
There's still time to triple your impact.